Cepheid, US DoD, Walter Reed to Develop RT-PCR Assay for Leishmaniasis | GenomeWeb

NEW YORK, April 26 (GenomeWeb News) - Cepheid and the US Department of Defense/Walter Reed Army Institute of Research intend to co-develop a Real-Time PCR reagent to detect Leishmaniasis in the field, the company said today.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.